metformina almus
almus s.r.l. - metformina - metformina
metformina doc
doc generici srl - metformina - metformina
metforaltag
laboratori guidotti s.p.a. - metformina - metformina
metformina pharmacare
pharmacare s.r.l. - metformina - metformina
yaltormin
pinewood laboratories limited - metformina - metformina
idroclorotiazide aurobindo
aurobindo pharma (italia) s.r.l. - idroclorotiazide - idroclorotiazide
sitagliptin e metformina galenicum
galenicum health, s.l. - metformina e sitagliptina - metformina e sitagliptina
metformina inventia
inventia healthcare bv - metformina - metformina
artesunate amivas
amivas ireland ltd - artesunate - malaria - antiprotozoari - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. dovrebbero essere prese in considerazione le linee guida ufficiali sull'uso appropriato degli agenti antimalarici.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.